Monday, July 25, 2011 6:40:46 PM
I jumped back into this stock after getting out of it last year at about this time (lost my ass). The reason I jumped backed in was the S-1 filing. I got an email from John last sept explaining why they couldn't tap the Dutchess financing. See below
VinWin can you explain the Prospectus filing. After looking the definition up there are 2 type a Prelimiary and a final Prospectus. I can't figure is this the Prelimiary or final. I'm thinking Prelimiary and the final will come later stating at what price and the amount of shares. I'm glad I been accumulating since Jul 1 and I made back what I lost and then some, but I"m still holding cause I think this was just the teaser PR the big one is coming. Like I stated last week that The reason why MMTC couldn't tap the Dutchess financing was because of the vol and PPS.
One more thing they are targeting the labs and the FDA that do all the bacterial testings. Think of this if your a lab and you can turn test out in 1/4 of the time and at a fraction of the cost. Do you think you would have leverage over other labs. Not only do MMTC get profit from the sale of the Product, but also receives revenue from the sales of the testing supplies and maintenence fees.
DOGMA
The below email was recieved last year in Sept
xxxx, sorry for not understanding your question. We have not been contacted by major media channels as of yet, but suspect we will once we get some traction.
xxxxx, Emily is “spot on” in her summary of testing within the dairy plant……….disposal of the bacteria is the problem. Only those companies that can afford to build a lab that is separate from their “production” do their own testing and even they also send a portion to outside labs for confirmation. So, contract labs in addition to the food processors are target customers for us. It would be better for us to talk with their contract lab instead of them.
The Dutchess equity draw down Agreement is very dependent on stock price and volume. We can only draw down cash based upon a portion of stock that they can sell. The actual formula is share volume*price*0.95. So at our current $.025 cent price, they would need to sell an average of 2M shares / day over a 10 day period for us to get $47.5K. Presently, our volume is about 200K/day, so this translates into about $9.5K/month. Our goal is to get our stock to upwards of 6 cents and our volume to 500K that would net us about $57K / month. We can draw down up to $5M given the aforementioned formula. So, this contribution is part of the $2.5M discussed. You should be able to get the details of the Dutchess Deal in our recently filed 10Q or by going to the SEC site for MMTC. If not, let me know and I will direct to the exact place.
Thanks again for your interest and support.
Best regards,
John
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM